Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Gradual changes often go unnoticed without baseline comparison
Not approved for diagnostic, therapeutic, or clinical applications.
The 2.5 mg dose is not intended for glycemic control
Consent for Publication Not Applicable
Exendin-4 Enhances Proliferation of Senescent Osteoblasts through Activation of the IGF-1/IGF-1R Signaling Pathway
Osmotic vs stimulant laxatives (OTC options) First-line pharmacologic option: Polyethylene glycol (PEG 3350) is recommended by gastroenterology guidelines because it increases stool water content, improves stool frequency, and is generally well tolerated for ongoing use. Alternative osmotic option: Magnesium oxide may help some patients and is conditionally recommended in gastroenterology society guidance
US$ 29.38
US$ 21.03
US$ 24.09
US$ 20.53
